首页> 外文期刊>Cerebrovascular diseases >Ischemic stroke survivors' opinion regarding research utilizing exception from informed consent.
【24h】

Ischemic stroke survivors' opinion regarding research utilizing exception from informed consent.

机译:缺血性卒中幸存者对利用知情同意书中的例外情况进行研究的观点。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: 'Exception from informed consent for research' (EFIC) is a rigorous procedure regulated by the FDA that requires community assent but allows enrollment without patient or family consent. Recently, several acute stroke trials have explored the use of EFIC to improve enrollment. We obtained ischemic stroke survivors' opinions regarding hypothetical enrollment into a clinical trial at the time of their stroke without personal or proxy consent. METHODS: During 2005, 460 ischemic stroke patients (or their proxy) who met case criteria were prospectively interviewed and followed. After 2 years, patients were asked to think back to the time of their stroke and indicate whether they would have wished to be enrolled in an acute stroke research study before individual or proxy consent could be obtained, understanding that consent would be sought as soon as possible thereafter, and they rated how agreeable they would have been to acute stroke research with different levels of invasiveness. Predictors of a positive opinion regarding the hypothetical research were analyzed using logistic regression. Variables included in the model were age, race, sex, education, initial NIHSS, modified Rankin Scale prior to stroke and 30 days after stroke, and proxy versus patient responder. RESULTS: At 2 years after stroke, after excluding patient deaths, missing data or refusals, there were 194 patient/proxy responses included in this analysis. Overall, 72-79% of responses were favorable for chart review or blood draw without consent. The proportions answering agreeably to questions about medications or invasive strategies were smaller (62.9 and 59.8%). Older subjects were less likely to offer an agreeable response regarding use of medications [OR 0.97 per year (95% CI 0.94-0.99)] and invasive procedures [OR 0.97 per year (95% CI 0.94-0.99)]. Nonblacks tended to be more agreeable than blacks to invasive procedures. Men had twice the odds of being agreeable to blood draws than women. CONCLUSIONS: We found that the majority of interviewed ischemic stroke patients were agreeable to being enrolled in acute stroke research with exception from informed consent, although the rates of agreement were lower than we expected among a cohort of patients who had already agreed to research. Older subjects, black race, and women were less likely to agree to blood draws or treatment strategies.
机译:简介:“研究知情同意书中的例外情况”(EFIC)是FDA规定的严格程序,需要社区的同意,但未经患者或家属同意即可入组。最近,一些急性中风试验已经探索了使用EFIC来改善入组率。未经他们或代理人的同意,我们就缺血性卒中幸存者在卒中时假想加入临床试验中获得了意见。方法:在2005年,对460例符合病例标准的缺血性中风患者(或其代理人)进行了前瞻性访谈和随访。两年后,患者被要求回想一下中风的发生时间,并指出他们是否希望在获得个人或代理人同意之前希望参加急性中风研究,了解到将尽快寻求同意。之后,他们评估了他们对于不同程度的浸润性急性卒中研究的满意程度。使用逻辑回归分析对假设研究的正面意见的预测因素。模型中包括的变量包括年龄,种族,性别,教育程度,初始NIHSS,中风前和中风后30天的改良兰金量表,以及代理人与患者的反应者。结果:卒中后2年,在排除患者死亡,数据丢失或拒绝之后,该分析包括194位患者/代理人响应。总体而言,未经同意,有72-79%的回答有利于图表检查或抽血。同意回答有关药物或侵入性策略问题的比例较小(分别为62.9和59.8%)。年龄较大的受试者就药物使用[每年OR 0.97(95%CI 0.94-0.99)]和侵入性手术[每年OR 0.97(95%CI 0.94-0.99)]不太可能提供令人满意的反应。非黑人倾向于比黑人更适合侵入性手术。男性接受抽血的几率是女性的两倍。结论:我们发现,除知情同意外,大多数接受采访的缺血性中风患者都同意参加急性中风研究,尽管同意率低于我们已经同意进行研究的队列中的预期。年龄较大的受试者,黑人种族和女性不太可能同意抽血或采取治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号